Researchers from the University of Kentucky in Lexington analyzed data from the Surveillance, Epidemiology, and End Results 22 registry database to compare the number of observed versus expected cancer diagnoses between January 2020 and December 2021.
The cancer incidence rate for all sites was 9.4% lower than expected in 2020 and 2.7% lower than expected in 2021, showing a slight improvement though still failing to meet expectations. The overall cancer incidence rate for both years was 6% lower than expected, equating to 149,577 potentially missed diagnoses.
Breast cancer diagnoses showed the greatest improvement in 2021, exceeding the expected rate by 2.5%. Lung cancer and cervical cancer diagnoses continued to fall behind expectations at 9.1% and 4.5%, respectively.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
